| abstract |
The present application relates to prodrug derivatives of 5-chloro-N-({(5S)-2-oxo-3-[2-fluoro-4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide, processes for production thereof, use thereof for treatment and/or prophylaxis of diseases and also use thereof for production of medicaments for the treatment and/or prophylaxis of diseases, in particular thromboembolic diseases. |